pharma distribution compliance

In today’s unforgiving pharmaceutical landscape, GDP compliance is no longer a box to check—it’s the make-or-break standard that defines operational survival and brand trust. Good Distribution Practice (GDP) has become more critical than manufacturing quality itself. A 2024 industry report found that 68% of drug recalls are now traced back to distribution failures, costing companies…